Qiaoting Hu

Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis

Chen Qu, Dandan Zheng, Sai Li et al. · Hepatology · 2018 · 105 citations · Full text

Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer

Juan Zhou, Jinjing Wang, Yun‐Yun Zeng et al. · Oncotarget · 2015 · 78 citations · Full text

Epithelial-mesenchymal Transition, Oncology, Inflammatory Lung Disease +15

MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence

Mingyu Liu, Qiaoting Hu, Mengxian Tu et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 70 citations · Full text

Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition

Juan Zhou, Qiaoting Hu, Xi Zhang et al. · Oncology Reports · 2018 · 16 citations · Full text

Dual inhibition of reactive oxygen species and spleen tyrosine kinase as a therapeutic strategy in liver fibrosis

Qiaoting Hu, Mingyu Liu, Yundan You et al. · Free Radical Biology and Medicine · 2021 · 15 citations

Immunology, Pathology, Cholangiopathies +20